Sanofi (SNY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 48.82 |
| Open | 48.61 |
| Bid | 48.62 x 400 |
| Ask | 48.68 x 400 |
| Day's Range | 48.31 - 48.67 |
| 52 Week Range | 42.63 - 55.72 |
| Volume | |
| Avg. Volume | 2,011,841 |
| Market Cap | 122.01B |
| Beta (5Y Monthly) | 0.44 |
| PE Ratio (TTM) | 24.96 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.04 (4.17%) |
| Ex-Dividend Date | May 09, 2024 |
| 1y Target Est | N/A |
- Zacks
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers are included in this Analyst Blog.
- Zacks
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
- FX Empire
Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
The past five days have been a rollercoaster for Novavax investors, as the share price of the company skyrocketed by over 200% following the announcement of a major deal with French pharmaceutical giant Sanofi.
© 2024 Yahoo. All rights reserved.